Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out of the hospital among patients with nonmetastatic bladder cancer. Perspective from David ...

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Patients requiring intraoperative conversion from robotic-assisted radical cystectomy to open surgery have higher 90-day mortality rates and 30-day readmission rates. Intraoperative conversion from ...

Impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes. SPADE: Design of a real-world observational study of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (UC ...

—A retrospective real-world study of patients with muscle-invasive bladder cancer showed that robot-assisted and laparoscopic radical cystectomy reduce post-surgical complication rates, compared to ...

Within 90 days of surgery, patients undergoing robotic surgery spent a median of 82 days alive and out of the hospital versus 80 days for open-surgery patients (adjusted difference 2.2 days, 95% CI ...

Robotic surgery for bladder cancer speeds recovery, reduces pain, and improves quality of life. It also significantly reduces risks such as blood clots and can preserve functions like sexual health.

The benefits of robotic surgery may have a more pronounced effect in octogenarians, according to investigators. Robotic-assisted radical cystectomy (RARC) for bladder cancer is safe and feasible for ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...